mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment. As ...

RNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in ...

An mRNA vaccine that targets several aspects of C. difficile’s ability to cause severe disease prevented major symptoms and death in mice.

The most recent trading session ended with Moderna (MRNA) standing at $57.73, reflecting a -0.96% shift from the previouse trading day's closing. This change lagged the S&P 500's daily gain of 0.77%.

Messenger RNA (mRNA) serves as a blueprint for proteins. When mRNA is no longer needed, it must be degraded. Director Elena ...

MRNA Vaccines: "The University of Sheffield's versatile RNAbox builds on the 'vaccine revolution' experienced during the ...

Moderna doses first participant in phase 3 trial of mRNA norovirus vaccine, mRNA-1403: Cambridge, Massachusetts Thursday, October 3, 2024, 12:00 Hrs [IST] Moderna, Inc, a global l ...

This growth has continued into 2024, with the rising value of licensing agreements reflecting growing confidence in this technology beyond application in vaccines. Global sales for innovator mRNA ...

Researchers from University of Science and Technology of China (USTC) published data for a novel multivalent mRNA mpox vaccine candidate, MPXV-1103.

Engineers have discovered a simple and inexpensive means of directing lipid nanoparticles (LNPs), the revolutionary molecules that delivered the COVID-19 vaccines, to target specific tissues, ...

The Hong Kong stock market’s pharmaceutical sector has seen a strong rebound recently. Among them, AIM Vaccine Co., Ltd. (06660.HK) led the rise in the ...